CINECA IRIS Institutional Research Information System

PETRINI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.177
AS - Asia 20.655
EU - Europa 19.428
SA - Sud America 3.021
AF - Africa 817
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 19
Totale 92.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.531
CN - Cina 6.624
IT - Italia 6.455
SG - Singapore 6.201
SE - Svezia 3.580
HK - Hong Kong 3.506
CA - Canada 3.395
BR - Brasile 2.598
DE - Germania 1.983
BG - Bulgaria 1.631
VN - Vietnam 1.161
GB - Regno Unito 1.151
TR - Turchia 1.150
PL - Polonia 1.054
UA - Ucraina 838
RU - Federazione Russa 758
FI - Finlandia 737
KR - Corea 562
IN - India 417
CH - Svizzera 337
CI - Costa d'Avorio 316
FR - Francia 238
AT - Austria 195
JP - Giappone 187
BD - Bangladesh 169
BE - Belgio 144
AR - Argentina 129
MX - Messico 126
SN - Senegal 125
IQ - Iraq 109
NG - Nigeria 88
PK - Pakistan 78
ZA - Sudafrica 77
SA - Arabia Saudita 73
ID - Indonesia 69
NL - Olanda 67
UZ - Uzbekistan 67
EC - Ecuador 65
ES - Italia 53
VE - Venezuela 53
CO - Colombia 45
AU - Australia 44
MA - Marocco 44
KE - Kenya 43
EG - Egitto 42
AE - Emirati Arabi Uniti 34
IL - Israele 34
CZ - Repubblica Ceca 32
CL - Cile 31
PY - Paraguay 30
UY - Uruguay 30
JM - Giamaica 25
BJ - Benin 24
IE - Irlanda 24
JO - Giordania 20
MY - Malesia 20
AZ - Azerbaigian 19
PH - Filippine 19
GR - Grecia 18
LT - Lituania 17
OM - Oman 17
BO - Bolivia 16
NP - Nepal 16
PE - Perù 16
TN - Tunisia 16
DK - Danimarca 15
IR - Iran 14
KZ - Kazakistan 13
PT - Portogallo 13
EU - Europa 12
HN - Honduras 12
PS - Palestinian Territory 12
TT - Trinidad e Tobago 12
DO - Repubblica Dominicana 11
HU - Ungheria 11
RO - Romania 11
AL - Albania 10
BB - Barbados 10
BY - Bielorussia 10
DZ - Algeria 10
PA - Panama 10
CR - Costa Rica 9
KG - Kirghizistan 9
NI - Nicaragua 9
RS - Serbia 9
EE - Estonia 8
ET - Etiopia 8
NZ - Nuova Zelanda 7
TW - Taiwan 7
GE - Georgia 6
GY - Guiana 6
MD - Moldavia 6
TH - Thailandia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AO - Angola 5
LB - Libano 5
QA - Qatar 5
AM - Armenia 4
BH - Bahrain 4
BS - Bahamas 4
Totale 92.082
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.315
Ashburn 4.299
Ann Arbor 4.259
Fairfield 3.509
Hong Kong 3.470
Singapore 3.327
Houston 3.323
Chandler 2.924
Santa Clara 2.522
Serra 2.356
Montreal 2.329
Dallas 1.725
Milan 1.669
Sofia 1.623
Seattle 1.554
Beijing 1.515
Shanghai 1.351
Wilmington 1.259
Cambridge 1.154
Jacksonville 1.118
New York 1.008
Ottawa 955
Boardman 801
Hefei 780
Princeton 755
Izmir 740
Lawrence 615
Los Angeles 585
Medford 577
Seoul 549
Nanjing 520
Des Moines 394
Dearborn 379
Dong Ket 329
Bern 319
Abidjan 315
Istanbul 301
Florence 295
Munich 256
Buffalo 240
Nanchang 237
Lancaster 225
São Paulo 211
London 202
Jüchen 197
San Diego 196
Redondo Beach 186
Ho Chi Minh City 180
Rome 178
Council Bluffs 167
Vienna 167
Redwood City 159
Boulder 151
Tokyo 146
Brussels 143
Frankfurt am Main 142
Pisa 139
Kunming 137
Bremen 136
Dakar 125
The Dalles 119
Shenyang 117
Columbus 116
Hebei 105
Changsha 103
Chicago 98
San Jose 96
Washington 88
Ogden 87
Hanoi 86
Lagos 86
Rio de Janeiro 83
Turku 82
Jiaxing 80
Fuzhou 76
Westminster 73
Düsseldorf 69
Pune 69
Tianjin 68
Tashkent 63
Norwalk 62
Falls Church 61
Belo Horizonte 59
Guangzhou 59
Warsaw 59
Phoenix 57
Dhaka 56
Hangzhou 55
Nürnberg 52
Quanzhou 52
Porto Alegre 48
Curitiba 46
Helsinki 46
Orange 45
San Francisco 43
Toronto 42
Ankara 40
Auburn Hills 40
Brooklyn 40
Denver 40
Totale 67.504
Salva come PNG Salva come JPEG
Nome #
EFFICACY AND TOXICITY PROFILES OF LOW-DOSE THALIDOMIDE AS MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS AFTER DOUBLE OR TRIPLE AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION. 3.404
1,25(OH)2D3 and TPA in vitro activity on B-CLL. 271
CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction 254
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 247
Is binding of vitamin D binding protein related to cell differentiation? 242
Atypical APL including multiple translocations and abnormal response to micronuclei induction test 239
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy. 238
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study 237
How Nanotechnology Can Really Improve the Future of Orthopedic Implants and Scaffolds for Bone Defects 236
EVALUATION OF RESISTANCE INDEX OF SEVERAL ANTICANCER AGENTS ON PARENTAL AND RESISTANT P-388 CELL LINES 231
Pore Size Distribution and Blend Composition Affect In Vitro Prevascularized Bone Matrix Formation on Poly(Vinyl Alcohol)/Gelatin Sponges 231
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 230
CD45 expression in low-grade B-cell non-Hodgkin's lymphomas 228
INDOMETHACIN INHIBITION OF BONE-MARROW GRANULOCYTE RELEASE INTO PERIPHERAL-BLOOD 226
Identification of miRSNPs associated with the risk of multiple myeloma 226
New approaches for imaging and therapy of solid cancer 223
Bone tissue engineering: Natural origination or synthetic polymeric scaffolds? 223
Inferential mining for reconstruction of 3D cell structures in Atomic Force Microscopy imaging 223
Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy, RECENTI PROGRESSI IN MEDICINA 219
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 219
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 215
Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy. 214
Plasticity of human dental pulp stromal cells with bioengineering platforms: A versatile tool for regenerative medicine. 214
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells 213
Glycosylation interference on RhoA activation: focus on G-CSF 213
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications 213
Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly. 212
Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing. 210
Expression of MDR1, MRP, TOPOISOMERASE-IIa, TOPOISOMERASE-IIb and GSTp in acute leukemias. 209
Identification and purification of mesodermal progenitor cells from human adult bone marrow. 208
Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study. 207
MESENCHYMAL CELLS INHIBIT IL2 AND ZOLENDRONATE-INDUCED ?/d T-LYMPHOCYTES 207
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 206
Could age modify the effect of genetic variants in IL6 and TNF-a genes in multiple myeloma? 204
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 204
Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation 203
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs) 202
1,25-Dihydroxyvitamin D3-mediated inhibition of human leukemic B cell precursors 201
CHEMOIMMUNOTHERAPY REGIMEN OF FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB FOLLOWED BY ALEMTUZUM- AB AS INITIAL THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA: A VALID APPROACH FOR ERADICATION OF MINIMAL RESIDUAL DISEASE 201
Processing large-diameter poly(L-lactic acid) microfiber mesh/mesenchymal stromal cell constructs via resin embedding: an efficient histologic method 201
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia. 199
Preparation of stable dispersion of barium titanate nanoparticles: Potential applications in biomedicine 199
β-Cell inflammation in human type 2 diabetes and the role of autophagy 199
Vitamin D binding protein is produced by human monocytes 198
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial 198
Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cells. 198
Alteraciones funcionales de los granulocitos neutrofilos en un joven neutropenico de raza negra 197
INTRA-LYMPHOCYTIC ADENOSINE-DEAMINASE AND PURINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA - EFFECT OF THYMOSTIMULIN 197
Infliximab treatment of grade IV skin acute graft versus host disease 197
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 197
Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing Camelia Sinensis leaf extract 197
Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulation 197
Novel biological/biohybrid prostheses for the ossicular chain: fabrication feasibility and preliminary functional characterization 197
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms 196
La storia della Facoltà di Medicina e Chirurgia 196
Activity of different revertant agents on multidrug resistance: in vitro evaluation of their combination 196
Immunomodulators and enzymes of purine metabolism in human lymphocytes 195
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 194
WT1 GENE EXPRESSION IS SIGNIFICANTLY INHIBITED BY VORINOSTAT AND BORTEZOMIB IN MYELOPROLIFERATIVE/MYELODISPLASTIC DISEASES 194
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 194
Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly 194
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 193
Phenotypic markers in chronic lymphocytic leukemia. 192
Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein. 192
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 192
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 192
HOX and TALE signatures specify human stromal stem cell populations from different sources. 192
Adenosine deaminase activity in human cord blood lymphocyte subpopulations. 191
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. 191
Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient 190
Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway. 189
Correction: Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment. 189
Mesangiogenic Progenitor Cells Derived from One Novel CD64brightCD31brightCD14neg Population in Human Adult Bone Marrow 189
EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA 188
Development of tissue-engineered substitutes of the ear ossicles: PORP-shaped poly(propylene fumarate)-based scaffolds cultured with human mesenchymal stromal cells. 188
Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA 188
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 188
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 187
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone 187
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 187
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 187
In vivo and in vitro effects of thymostimulin (TP-1) on immunodeficiencies 186
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature 186
Unexpected cardiotoxicity in haematological bortezomib treated patients 185
Expression of p170 protein in multiple myeloma : a clinical study 184
A case of Staphylococcal toxic shock syndrome with expansion of TCR alphaBeta+, CD4/CD8 double negative lymphocytes 184
Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow Cytometry 184
Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation 184
NEUROENDOCRINE MODULATION OF ALLOGRAFT REJECTION BY DOPAMINE AGONISTS 183
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma. 183
Dipeptidyl-Peptidase 4 (Cd26): a Possible Therapeutic Target in Covid-19 182
The effects of lithium and rubidium on human leukocyte functions 181
Synergistic effects of alpha interferon and 1,25 dihydroxyvitamin D3: Preliminary evidence suggesting that interferon induces expression of the vitamin receptor 181
Modulation of glycoprotein P in the primary culture of rat hepatocytes 181
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 181
Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL). 180
Multidrug Resistance and electromagnetic fields 180
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease 180
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 180
Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report., LEUKEMIA RESEARCH,pp 00,tot.pag 00,tot. autori 7,2007 179
Totale 23.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 243.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 243.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.199 0 0 0 0 0 203 412 453 406 366 427 932
2021/20227.297 157 425 209 573 1.357 936 183 325 345 183 562 2.042
2022/20238.835 1.199 1.185 605 824 951 1.185 82 709 1.397 40 582 76
2023/20249.686 930 766 832 445 993 1.131 214 175 87 3.378 132 603
2024/202519.042 68 705 138 1.187 1.830 1.818 1.565 1.072 1.806 2.554 2.043 4.256
2025/202611.450 1.212 2.549 2.207 1.518 1.974 1.990 0 0 0 0 0 0
Totale 93.027